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http:WHAT THIS PAPER ADDS
This study presents the results of an original and straightforward “off-label” approach to EVAR for atypical
presentation of AAA and common iliac artery aneurysms, when the use of standard endografts is contra-
indicated or challenging. Iliac leg endografts and covered stent-grafts are delivered in a parallel fashion from
proximal aortic to distal iliac landing zones, always preserving prograde ﬂow to at least one internal iliac artery.
Aneurysm exclusion and target vessel patency was achieved in all patients postoperatively and during the
median 26-month follow-up. Commercially available endografts were used in a simple and effective approach
with excellent results.Objectives: Endovascular treatment of distal abdominal aortic aneurysms (D-AAA) and bilateral common iliac
artery aneurysms (BCIAA) may present technical challenges for standard EVAR. Parallel iliac leg endografts (ILEs)
of standard aortic devices and covered stents have been successfully employed to treat patients with D-AAA and
BCIAA. The perioperative and long-term results of this straightforward endovascular technique are presented.
Methods: Beginning in 2009, patients deemed unﬁt for open surgery underwent parallel endografts D-AAA and
BCIAA exclusion. Avoiding the use of a main body, ILEs are simultaneously delivered from both femoral arteries,
landing parallel into the aortic neck (parallel grafts: PG). Distal landing zones including external iliac arteries (EIAs)
are reached using appropriate ILEs. A third parallel covered stent graft (Viabahn, Gore) is delivered from a left
brachial approach to maintain prograde blood ﬂow to one internal iliac artery (IIA) when needed.
Results: Eighteen patients were successfully treated using parallel endografts, nine for BCIAA and nine for D-AAA.
All D-AAA presented an irregular saccular shape, including three penetrating aortic ulcers and two
pseudoaneurysms of previous aortic grafts. Prograde ﬂow to one IIA was successfully maintained using a Viabahn
graft in ﬁve patients with BCIAA. Mean aneurysm size was 50 mm in D-AAA and 43 mm in BCIAA. One patient
required a perioperative ILE extension to treat a type Ib endoleak. One patient suffered a minor stroke 24 hours
after the procedure. Two type II endoleaks were observed postoperatively. Five patients died of non-aneurysm
related causes during follow-up. No new endoleaks, graft displacements or occlusions were observed during
follow-up (median: 26 months, range 12e42 months).
Conclusions: Successful exclusion of D-AAA and BCIAA was achieved in high-risk patients using parallel
endografts, allowing antegrade blood ﬂow to one IIA when needed. Commercially available endografts were used
in a simple and effective approach, with excellent follow-up results.
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//dx.doi.org/10.1016/j.ejvs.2014.03.017asymmetric saccular aneurysms and common iliac artery
(CIA) aneurysms without suitable landing zones are the
commonest contraindications to commercially available
endografts.
Although speciﬁc epidemiological data are not available,
saccular aneurysms involving the infrarenal abdominal aorta
are rare and usually the result of penetrating aortic ulcers
(PAUs) or pseudoaneurysm following previous aortic
reconstruction. Elective repair should be considered for all
patients that present with asymmetric saccular aneurysm,1
because there is an increased risk of rupture.2 When
saccular aneurysms occur in the distal aorta (D-AAA) the
presence of a long aortic neck, restricted longitudinal
30 S. Lepidi et al.extension of the aneurysm, asymmetrical aneurysm spatial
distribution, and the possible presence of calciﬁed plaques
inside the sac in PAU may create technical challenges for
bifurcated endografts, because of possible incomplete
opening and/or partial obstruction of the contralateral iliac
branch against the aortic wall. Although treatment with
aorto-uni-iliac (AUI) endografts may be offered in some
cases, contralateral iliac artery occlusion is mandatory to
avoid type I endoleak and a concomitant extra-anatomic
bypass is required to maintain lower limb perfusion.
AAAs involve the iliac arteries in 20e30% of cases,3,4
whereas isolated CIA aneurysms (without AAA) are rare,
representing only 1e2% of all intra-abdominal aneu-
rysms.4,5 Bilateral CIA aneurysms (BCIAAs) are present
approximately 50% of the time.6 Treatment of CIA aneu-
rysms is recommended when the diameter exceeds
30 mm.7
BCIAA present both clinical and technical challenges
when they involve the entire length of the artery. When
aneurysms extend to iliac bifurcations, the only distal im-
plantation site is in the external iliac artery (EIA), and pro-
grade ﬂow to both internal iliac arteries is lost. Concomitant
bilateral internal iliac artery (IIA) occlusion presents a
consistent risk of pelvic ischemia, including symptoms of
buttock claudication and erectile dysfunction. Although
opinions vary widely regarding the dangers of bilateral IIA
embolization, the current standard practice for EVAR in the
presence of bilateral common iliac aneurysms involves
catheter-based proximal IIA occlusion and some attempt to
preserve ﬂow to at least one IIA.1,7 The iliac branch device
(IBD, Cook Medical Europe, Bjaeverskov, Denmark) is now
available to treat CIA aneurysm and to preserve ﬂow to the
IIA. However, it is required to deliver IBD with an aortic
endograft (Zenith Flex) presenting suprarenal ﬁxation.
Therefore, IBD is indicated in the treatment of CIA aneu-
rysm associated with AAA and not of isolated BCIAA.
To overcome the limitations of currently available stan-
dard endografts and to simplify the EVAR technique, a
simple “off-label” technique8 has been devised using
commercially available iliac leg endografts (ILEs) of standard
AAA devices and covered stent-grafts, delivered in a parallelFigure 1. Three-dimensional computed tomography scan reconstructio
metric saccular distal abdominal aortic aneurysm (D-AAA) (B) and asymm
aortic reconstruction (C).fashion (parallel grafts, PGs) from proximal aortic to distal
iliac landing zones. This procedure (PG-EVAR) has been
offered to patients with D-AAA and BCIAA, in challenging
clinical and anatomical situations.
The aim of the present study is to report preoperative
patients’ clinical and anatomical characteristics, periopera-
tive data as well as follow-up results of PG-EVAR.MATERIALS AND METHODS
Patients and anatomical evaluation
All patients with aortic or iliac aneurysms treated by PG
exclusion were searched for in a prospectively maintained
hospital database and data were retrieved for analysis.
Comorbidities were classiﬁed according to the Society for
Vascular Surgery (SVS) grading system.9 Only high-risk pa-
tients with comorbidities unsuitable for open surgery were
considered candidates for PG-EVAR. These included patients
with poorly compensated or recurrent congestive heart
failure, ejection fraction 35%, severe aortic valve stenosis,
myocardial infarction within 6 months, symptomatic or
poorly controlled ectopy/arrhythmia (chronic/recurrent),
pulmonary dysfunction (forced expiratory volume in 1 sec-
ond of 1 L), or requiring oxygen replacement therapy.
Moreover, patients having had previous major abdominal
surgery for cancer and patients with a hostile abdomen as a
result of multiple prior abdominal procedures were also
considered for PG-EVAR. Patients were preoperatively
evaluated by attending physicians, hospital anesthesiolo-
gists, and cardiologists when more accurate assessments
were needed.
All patients underwent abdominal and thoracic
computed tomography (CT) scan examination and DICOM
images were analyzed on a PC workstation using the Osirix
Pro 4.0 software (Pixmeo, Geneva, Switzerland). Thoracic CT
images were evaluated for arch and left subclavian anatomy
when an endograft to the internal iliac artery was planned.
Indications for PG-EVAR for infrarenal AAA included
irregular-shaped saccular aneurysms associated with a long
proximal neck (45 mm), considered challenging for stan-
dard bifurcated aortic endografts (Fig. 1B,C). Indications forns of isolated bilateral common iliac artery aneurysms (A), asym-
etric saccular D-AAA due to a pseudoaneurysm following previous
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maximal diameter 35 mm, on at least one side, without
suitable proximal landing zones in the common iliac ar-
teries. Contraindications to PG-EVAR were considered to be
a proximal neck smaller than 20 mm or greater than 27 mm
in mean diameter. When PG-EVAR was contraindicated,
different endovascular approaches were considered such as
an aorto-uni-iliac endograft or an iliac branched device. The
local University Hospital Board approved the study meth-
odology and design, and written informed consent was
obtained for all patients.
No patients with ruptured or leaking aneurysms were
treated with PG-EVAR. No devices were modiﬁed or altered
before implantation.
Procedural technique
All procedures were carried out in a hybrid surgical room
with a portable C-arm ﬂuoroscope.
Patients underwent general or epidural anesthesia with
sedation. Through small (3e5 cm) longitudinal incisions
both femoral arteries were surgically exposed as well as the
left brachial artery (LBA) when needed. Percutaneous ac-
cess to the femoral arteries was achieved in some patients
utilizing the Prostar XL Vascular System (Abbott, Abbott
Park, IL, USA). Systemic heparin sodium (5,000 units by iv
injection) was given. Over a hydrophilic 0.035-guidewire,
10F 12-cm-long (Terumo Europe, Leuven, Belgium) sheaths
were inserted into both common femoral arteries and a 5F
12-cm-long sheath (Terumo) into the LBA.Figure 2. Schematic algorithm showing the endovascular treatment stra
iliac artery. BCIAA ¼ bilateral common iliac artery aneurysms; IIA ¼ inte
Ipsi-lt ¼ ipsilateral; contra-lt ¼ contralateral. Plug: Amplatzer VascularFrom both femoral approaches a hydrophilic 0.035-
guidewire was advanced into the abdominal aorta and a
wire exchange was made for a superstiff 0.035-inch Lun-
derquist wire (Cook) through an angiographic pigtail 5F
catheter. Angiography in appropriate C-arm projections was
performed to precisely locate the renal artery and IIA ori-
gins. Both femoral sheaths were exchanged for longer
sheaths (45 cm) of appropriate size (12e18F).
In D-AAA, ILEs were introduced and simultaneously
deployed using the roadmap, with their proximal edge at
the same level in the aortic neck (Excluder, WL Gore, Flag-
staff, AZ, or Zenith Flex, Cook). When required, ILE exten-
sions of appropriate diameters and lengths were used to
reach suitable distal landing zones.
In BCIAA, ILEs were deployed in the CIA when appro-
priate (2 cm) distal landing zones were present or in
external iliac arteries (EIAs) when aneurysms extended to
CIA bifurcations. The endovascular treatment strategy was
always aimed at preservation of prograde blood ﬂow to one
IIA, according to the ﬂowchart in Fig. 2 based on aneurysm
extension to one or both iliac bifurcations and on patency
of one or both IIAs.
When required, one IIA was ﬁrst occluded using vascular
plugs (Amplatzer, St. Jude Medical, St. Paul, MN, USA)
delivered from the contralateral femoral artery or LBA ac-
cess. When delivery of covered stents (Viabahn, Gore) was
planned, a longer introducer (65 mm) was positioned in the
abdominal aorta from the left brachial access, with size
ranging from 8 to 11F depending on the diameter oftegy aimed at preservation of prograde blood ﬂow to one internal
rnal iliac artery; An ext to bif ¼ aneurysm extending to bifurcation;
Plug.
Table 1. Demographics, pre- and perioperative characteristics of
the 18 patients who underwent parallel endograft aneurysm
exclusion.
Variable No. of patients (%)
or median (range)
(N ¼ 18)
Demographics
Sex (male) 17 (94)
Age (years) 77 (65e88)
Risk factors
Hypertension 15 (83)
Hyperlipidemia 10 (55)
Diabetes 3 (17)
History of smoking 15 (83)
Active smoker 4 (22)
Preoperative comorbidities
Cardiac disease 12 (67)
Previous myocardial infarction 4 (22)
PTCA þ stent 5 (28)
32 S. Lepidi et al.covered stents. Using a 5F multi-purpose catheter and a
standard hydrophilic 0.035 guidewire access to the targeted
IIA was obtained, and a wire exchange made for a Lun-
derquist guide. Over the superstiff wire, Viabahn grafts of
appropriate diameters (8e10 mm) were deployed from the
targeted IIA to the proximal landing zone. Two covered
stents were used with 2 cm overlap to reach the required
length, when needed. The ILEs were then delivered as
described above with their proximal edges landing 5 to
10 mm distal to the proximal edge of the Viabahn graft
(Fig. 3). After release, iliac and Viabahn endografts were
dilated using compliant and non-compliant balloon cathe-
ters respectively. Special attention was given to simulta-
neous dilatation of endografts at the level of the proximal
landing zone.
Since 2010, aneurysm sac embolization has been per-
formed routinely using coils and ﬁbrin glue perioperatively,
as previously described.10Figure 3. Schematic drawing of parallel graft endovascular repair
procedure, showing BCIAA extending to both iliac bifurcations
treated with iliac leg endografts to both external iliac arteries,
covered stent-graft to one IIA and Amplatzer vascular plug to the
contralateral IIA.
CABG 2 (11)
Chronic heart failure 2 (11)
Ejection fraction <35% 3 (17)
Renal insufﬁciency
(creatinine >1.5 mg/dL)
6 (33)
COPD 5 (28)
Associated lower limb PAOD 3 (17)
Previous CV event 2 (11)
Other comorbidities
Hostile abdomen 4 (22)
Associated abdominal malignancy 4 (22)
Thrombocythemia 1 (6)
Recurring bowel obstruction
(Parkinson’s disease)
1 (6)
ASA III 13 (72)
ASA IV 3 (17)
Preoperative anatomical characteristics
D-AAA (N ¼ 9)
Aortic ulcer 3 (33)
Pseudoaneurysm 2 (22)
Max DAAA diameter, mm 50 (42e67)
BCIAA (N ¼ 9)
Extending to one iliac bifurcation 5 (55)
Extending to both iliac bifurcation 3 (33)
Max BCIAA diameter, mm 43 (35e55)
Perioperative characteristics
Fluoroscopy time (min) 25 (15e50)
Contrast dose (mL) 85 (50e180)
Operative time (minutes) 105 (80e210)
Estimated blood loss (mL) 55 (20e400)
Length of stay (days) 3 (2e20)
CABG ¼ coronary artery bypass grafting; COPD ¼ chronic
obstructive pulmonary disease; PTCA ¼ percutaneous
transluminal coronary angioplasty; PAOD ¼ peripheral arterial
obstructive disease; CV ¼ cerebrovascular; D-AAA ¼ distal
abdominal aortic aneurysm; BCIAA ¼ bilateral common iliac
artery aneurysms.Completion angiography was performed to assess the
correct endograft position, absence of stent stenosis, iliac
artery perfusion, and for the presence of any type of
endoleak.
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measured to plan for a 15% standard oversizing, when IIA
was not targeted and for a slightly increased oversize 20%,
when covered grafts were deployed.Postoperative management and data presentation
Double antiplatelet drugs (clopidogrel and aspirin) were
given for at least 1 month, followed by lifelong single an-
tiplatelet therapy.
A contrast CT scan was performed before discharge, be-
tween 3 and 6 months postoperatively, and annually
thereafter. Non-contrast CT and duplex were performed in
patients with renal insufﬁciency. Clinical follow-up included
physical and laboratory examinations focusing on pelvic
ischemia symptoms at 1 month, 6 months, and yearly
thereafter if no complications were observed.
All clinical, anatomical, and operative data were prospec-
tively collected in the hospital database and retrieved for the
study analysis. Primary end points were technical success
(successfully completed procedure with endograft patency,
preservation of target vessels, and no evidence of type I or III
endoleak at post-procedural imaging), 30-day mortality and
morbidity. Follow-upwas focused on all-causemortality, branch
vessel patency, renal impairment, and secondary interventions.
Owing to the small number of patients no control groups were
selected for the study and data are presented in a descriptive
analytic method. Categorical data are described using absolute
numbers and percentage of prevalence (%) in the study cohort,
whereas continuous variables are presented asmedian (range).
Independent two-sample t tests were used with a signiﬁcance
level of .05 (Microsoft Excel 2011, software 14.2.4).
RESULTS
From January 2009 to August 2012, 18 patients underwent
PG-EVAR, nine for saccular D-AAA and nine for BCIAA.Table 2. Aorta and common iliac artery characteristics.
Pt Treatment indications Distal-AA Mid-AA Pr
1 DAAA 46 21 20
2 BCIAA 27 26 18
3 DAAA 46 20 22
4 BCIAA 35 22 20
5 DAAA 45 20 18
6 BCIAA 33 24 21
7 DAAA 50 25 25
8 DAAA 42 22 18
9 BCIAA 21 20 20
10 BCIAA 41 21 20
11 BCIAA 25 19 19
12 BCIAA 40 22 21
13 BCIAA 26 25 20
14 DAAA 47 23 22
15 DAAA 67 19 21
16 BCIAA 21 18 19
17 DAAA 45 27 21
18 DAAA 45 26 20
Distal-AA ¼ maximal diameter of the distal infra-renal aorta; Mid-A
AA ¼ diameter 5 mm distal to the lowest renal artery; CIA ¼ commoSeventeen patients were male (94%), presenting a median
age of 77 years (range 66e88 years).
Comorbidities presented in Table 1 were typical of this
high-risk cohort of peripheral artery disease patients and
included severe hypertension (83%) requiring two or more
drugs, statin-treated hyperlipidemia (55%), history of
smoking (83%), severe cardiac disease (67%), stage III or
worse congestive heart failure (17%), severe chronic
obstructive pulmonary disease (28%), and renal insufﬁ-
ciency with serum creatinine >1.5 mg/dL (23%). The me-
dian SVS cardiac, respiratory, renal, hypertension and age
scores were 8, 4, 2, 3, and 2, respectively, with a median
total SVS score of 16 (range 1e24). Thirteen patients (72%)
were American Society of Anesthesiologists (ASA) class III
and three patients (17%) were class IV, and were felt by the
in-hospital cardiologist and operative team to be unsuitable
candidates for major open surgery.
Four patients (22%) presented with hostile abdomen due
to multiple previous intra-abdominal procedures, two of
them having a colostomy in the iliac fossa, associated in one
with a urostomy on the contralateral side. In four patients,
aneurysms were discovered during preoperative screening
for a concomitant cancer (2 kidney, 1 gastric, and 1 bladder)
and PG-EVAR was planned before major abdominal surgery
for cancer treatment.
One relatively young (59 years) male patient without sig-
niﬁcant comorbidities refused open surgery for a BCIAA
extending to one iliac bifurcation because of concerns about
postoperative erectile dysfunction. After a comprehensive
informed discussion on the risks and beneﬁts of this “off-
label” approach, he was offered a PG-EVAR to preserve blood
ﬂow to both IIA, using Viabahn endografts on one side.
In Table 2, aneurysm characteristics are reported in detail
for each patient.
Themedianmaximumaneurysmdiameterwas 43mm(35e
55 mm) in BCIAA (ﬁrst quartile, 40; third quartile, 51; IQR, 11),ox-AA Right CIA Left CIA Aneurysms to CIA bif.
12 12 No
41 18 R
12 12 No
52 55 L þ R
14 12 No
40 18 R
12 12 No
16 14 No
23 50 No
25 36 L
35 18 R
32 45 L þ R
17 43 L
12 16 No
12 12 No
51 30 L þ R
14 18 No
12 12 No
A ¼ diameter 45 mm distal to the lowest renal artery; Prox-
n iliac artery; Bif. ¼ bifurcation; L ¼ left; R ¼ right.
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quartile, 52.5; IQR, 7). Two D-AAA patients were treated for
small rapidly enlarging saccular aneurysms (42 and 45 mm)
and one for aneurysm (46 mm)-related abdominal symptoms.
The diameters of the infrarenal abdominal aorta were within
normal ranges up to its mid-portion (45 mm distal to the
lowest renal artery) in all patients and along its entire length in
ﬁve patients (isolated BCIAA). Four BCIAA patients presented
concomitant small distal AAA. In ﬁve BCIAA patients (55.5%),
the aneurysm extended to one iliac bifurcation and in three
(33.3%) to both.
Twelve patients underwent general anesthesia and six
epidural anesthesia with sedation. Only two patients un-
derwent a totally percutaneous access using the Prostar
System, due to recent device availability.Table 3. Endovascular materials and follow-up data.
Pt. Right iliac
endografts
Left iliac
endografts
IIA Viabahn IIA occl.
1 PXC141200 PXC141200 e e
2 PXC121400 PXC141200 PAC 081502 Left¼
chronic occl.
3 PXC161200
PXL161207
PXC161200
PXL161207
e e
4 PXC121400
PXL161207
PXC121400
PXL161207
PXC121200
PAC 081502
PAC 081002
Left¼
9-PLUG-010
5 PXC 161200 PXC161200 e e
6 PXC 141400 PXC141200 e Right¼
chronic occl
7 PXC141200 PXC141200 e e
8 PXC161400 PXC161200
PXC121000
e e
9 TFLE 2090
ESLE2055
TFLE 1690
ESLE 16-55
e e
10 PXC 201200 PXC141200
PXL161207
Smart 10  4
e Left¼
9-PLUG-010
11 PXC141200 PXC121400 PAH 081502
PAH 081002
e
12 PXC121400
PXL161207
PXC121400
PXL161207
PAH 091502
PAH 091502
Right¼
9-PLUG-010
9-PLUG-012
13 PXC181000 PXC121200
PXC121400
e Left¼
9-PLUG-012
9-PLUG-016
14 PXC181200 PXC141000 e e
15 PXC121400 PXC121400 e e
16 PXC121400
PXC 121200
PXC121400
PXC121200
PAH 101502
PAH 100502
Right¼
9-PLUG-014
17 PXC 16-1400
PXC 161000
PXC161400
PXC161200
e e
18 PXC 141200 PXC141200 e e
PXC ¼ Excluder ILE; PXC ¼ Excluder ILE extensions; TFLE ¼ Zenith Fle
uncovered stent from Cordis; PAC ¼ Viabahn without Heparin Bio
Occl. ¼ occlusion; 9-PLUG ¼ Amplatzer Vascular Plug; F/U ¼ follow
CHF ¼ congestive heart failure; ARDS ¼ acute respiratory distress synAll the procedures were technically successful with
aneurysm exclusion and patent Viabahn graft. One patient
presented with a type Ib endoleak at the ﬁnal angiogram
which resolved immediately with an extension ILE.
The median length of the procedure was 105 minutes
(80e210 minutes), ﬂuoroscopy time 25 minutes (15e50
minutes), contrast dose 85 mL (50e180 mL), and estimated
blood loss 55 mL (30e400 mL). When Viabahn endografts
and/or IIA plug occlusion were not required, the median
length of the procedure (50 minutes, range 40e90 minutes),
ﬂuoroscopy time (15 minutes, range 12e23 minutes),
contrast dose (55 mL, range 30e110 mL), and estimated
blood loss 40 mL (30e200 mL) were all signiﬁcantly lower
than in patients undergoing a concomitant IIA procedure
(p < .05 for all 4 parameters).F/U
(mo)
Aneurysm
shrinkage
(mm)
Complications
42 20 e
40 5 Postop left hemispheric stroke
Good follow-up functional recovery
28 19 Death from un-related MOF at 43 mo
30 16 Post-op type II EL, resolved at 12 mo.
48 10 e
27 10 Death from CHF at 28 mo
36 10 e
36 12 e
13 10 Death from ventricular arrhythmia at
26 mo
26 2 e
25 5 e
14 5 Bowel Obstruction
e e Death in ICU <30days after
major surgery for gastric cancer
16 9 e
14 þ5 Postop type II EL, postop ARDS
Persistent type II EL at 12 mo
Death from pancreatic cancer at 15 mo
22 16 e
13 17 e
12 5 e
x ILE; ELSE ¼ Zenith Flex ILE extensions; Smart ¼ self-expanding
active Surface; PAH ¼ Viabahn with Heparin Bioactive Surface;
-up; Mo ¼ months; MOF ¼ multi organ failure; EL ¼ endoleak;
drome.
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Table 3. Gore Excluder ILEs were used in 17 patients and
Cook Zenith Flex in one. The Zenith ILE was chosen because
of better suitability of ILE proximal and distal diameters to
the anatomical characteristics of the patient. In nine pa-
tients a single ILE per side was used; in ﬁve, two ILEs per
side; in three, one ILE on one side and two on the contra-
lateral; and in one, two on one side and three on the
contralateral (ILE extension for a type Ib endoleak). In one
patient a self-expanding stent SMART Control (Cordis, J&J
Medical, Miami, FL) was delivered to attain better EIA
endograft apposition. Two overlapping Viabahns were
delivered in four patients, and a single Viabahn in one pa-
tient. The median distance between the lower renal artery
and the proximal ILE landing zone was 5.3 cm (range 3e
6.4 cm) in BCIAA, and 1.8 cm (range 0.8e2.5 cm) in D-AAA.
Aneurysm sac exclusion using coils and ﬁbrin glue was
accomplished in nine patients.
One patient with concomitant D-AAA and gastric cancer
underwent a successful PG-EVAR and was transferred to the
General Surgery Division without clinical complications and
with normal blood tests. He underwent surgery for gastric
cancer and died in the intensive care unit for MOF 2 days
after the second procedure.Figure 4. Postoperative angio-CT scan showing the successful PG-EVAR o
to the level of the angio-CT scan cross-sections on the right panel, show
sign of endoleak in the excluded aneurysms.One patient presented with immediate post-procedural
right arm monoplegia. The following CT scan showed a
left hemispheric stroke in the left carotid artery territory.
The patient was transferred to a rehabilitation unit where
he achieved a good functional recovery.
Other postoperative complications included severe res-
piratory insufﬁciency in one patient suffering from severe
chronic obstructive pulmonary disease and one case of
bowel obstruction in a patient with Parkinson’s disease
suffering from recurring bowel obstruction. Both patients
were transferred to other divisions and were discharged
with resolution of complications under medical therapy
after 20 and 14 days respectively. The median overall hos-
pital length of staying was 3 days (2e20 days).
Two type II endoleaks were detected at the postoperative
CT scan; one disappeared and the other persisted leading to
a slight increase in sac diameter (5 mm) at the 1-year CT.
The last patient died 15 months after the PG-EVAR with
complications of pancreatic cancer. Another four patients
died during follow-up from causes unrelated to the aneu-
rysm (Table 3).
Follow-up CT (Fig. 4) and Duplex scans showed patency of
all ILE and Viabahn grafts without any sign of stenosis in the
endografts and/or treated arteries at the median follow-up off isolated BCIAA (Fig. 1A: preoperative CT). The white arrows point
ing perfect alignment of the three grafts to the aortic wall and no
36 S. Lepidi et al.26 months (range 10e42 months). Except for the patient
presenting a type II endoleak described above, no aneurysm
has enlarged, with a median maximum sac diameter regres-
sion for the entire cohort of 10 mm (range20 toþ5 mm) at
latest follow-up. The proximal and/or distal landing zones
show no sign of aneurysm development during follow-up.
DISCUSSION
The use of parallel ILE at our institution has been derived
from the concept of the chimney graft technique, ﬁrst
described by Greenberg et al.11 as a bailout procedure in
2003. This “off-label” technique has been improved and
expanded successively by other authors12e14 to restore ﬂow
in aortic branches accidentally or intentionally covered and
to obtain an adequate seal during TEVAR in the aortic arch,
for patients with juxta-renal aortic aneurysms (JRAAs), and
in urgent cases when off-the-shelf devices need to be
employed. Many studies of the CG technique have been
published, with relatively good peri-operative and short-
term results as described by Moulakakis et al.14 in the
meta-analysis evaluating the results of 15 recent reports of
the technique for JRAA.
The parallel endografts in PG-EVAR present identical prox-
imal diameters and neither space competition nor graft in-
folding is created as it is for a main body endograft with
smaller chimney grafts to visceral and/or renal vessels.
Compliant balloon dilation effectively adjusts ILEs on the
endoluminal aortic surface. Contralateral limbs from Gore
were routinely used, except in one case. The sum of the
proximal diameter of the two limbs measured 32 mm
(16 þ 16 mm) and they were delivered in an aortic neck
20 mm. In all cases perfect adaptation of the two stents to
the aortic wall was observed after molding, even if the
measured oversizingwas large (about 35e40%) in some cases.
In the authors view the standard concept of proximal neck
oversizing in these cases cannot be compared to the oversizing
used for the main body endograft of a standard EVAR.
Moreover, when one IIA was targeted the covered stent-
grafts were ﬁrst delivered and naturally engaged the space
between the ILEs subsequently released in the proximal
landing zone. Therefore, the in-folding of engrafts is
distributed between the two ILEs and the risk of type Ia
endoleak from gutters minimized. Different ILE/stent-graft
diameters and lengths are commercially available to ﬁt
different aorto-iliac anatomies.
The concept of PG has recently been applied to a new
commercially available endograft (Nellix, Endologix, Inc.,
Irvine, CA, USA) in association with aneurysm sac sealing
(EVAS). EVAS using coils and ﬁbrin glue has also been
applied since 2010 in the present study. Although it has not
yet been approved for marketing in the United States, the
Nellix system is already CE marked.
The median time of the procedure (105 min), estimated
blood loss (55 mL), volume of contrast medium (85 mL), and
X-ray exposure time (25 min) demonstrate that PG-EVAR is
a straightforward technique. It is even more favorable in
this cohort of high risk patients when the procedure con-
sists of delivery of ILEs without IIA plug occlusion and/orViabahn graft. Although 89% of the patient cohort was ASA
class III and IV, only one patient died after the PG-EVAR and
a subsequent gastric cancer surgery.
One patient in this series suffered a perioperative ischemic
stroke in the territory of the left carotid artery and had a left
brachial access. Ischemic stroke in the left carotid cerebral
area could be explained by wire manipulation across the
aortic arch, but it is also possible fromdistal femoral accesses.
During standard EVAR, inadvertent cannulation of an arch
vessel may lead to plaque disruption and stroke. Stroke
complications are reported during CG-EVAR and represent a
limitation of the procedure. In the meta-analysis presented
by Moulakakis et al.,14 ischemic stroke was observed in 3.2%
of patients. The diameter reduction of the delivery system
associated with the new low-proﬁle devices should help to
reduce these complications.
The other two postoperative complications (bowel
obstruction and respiratory insufﬁciency) were related to
patients’ preoperative clinical conditions and resolved after
medical treatment.
No type Ia endoleak was observed postoperatively or
during the median 26 (12e42) months of follow-up. As it is
in all parallel graft techniques, type Ia endoleak along the
stent graft gutters is also a potential risk in the PG-EVAR
technique. The long juxtaposition of the parallel grafts in
the proximal aortic neck (>3 cm in all cases) may explain
the absence of any type Ia endoleaks in the present series.
Aneurysm shrinkage (median 10 mm) was observed in all
patients except one who presented a slight sac increase
(þ5 mm) due to a persistent type II endoleak after 12
months. A closer follow-up with possible secondary inter-
vention was planned but unfortunately the patient died
from unrelated causes after 15 months.
A clear limitation of the present study is that this is
neither a randomized nor a controlled trial with any com-
parisons and results should be interpreted cautiously. The
small number of expected patients (high physiologic risk in
selected AAA anatomies) would have made any statistically
signiﬁcant conclusion difﬁcult to reach with any possible
control group.
The median aortic aneurysm diameter was small (50 mm)
and the indications for treatment were related to the
asymmetric presentation of the saccular aneurysms in many
patients. Treatment with standard bifurcated or aorto-uni-
iliac (AUI) endografts (Zenith Flex/AUI or Endologix Power-
link/AXF) would have been technically possible in some pa-
tients in this series. However, PG-EVAR was considered a
quicker and more suitable approach for these high-risk pa-
tients, avoiding the contralateral branch cannulation in the
bifurcated graft, retrieval of a guidewire from the contralat-
eral femoral side in the Powerlink/AXF and contralateral iliac
plug occlusion and an extra-anatomical crossover bypass in
AUI. A crossover femoro-femoral bypass was also contra-
indicated in two patients with colostomies and urosotomy in
the iliac fossa, due to risk of contiguous infection.
Similar concerns with use of standard endografts were
also present in four BCIAA patients presenting with
concomitant small aneurysms of the distal aorta.
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patients presenting without aortic dilatation (5 patients) and
in those requiring preservation of ﬂow to the IIA (5 patients).
The absence of a non-dilated segment of proximal common
iliac artery necessitates proximal implantation of a bifurcated
or AUI endograft in the aorta, usually along its entire length.
Therefore, this procedure should be considered “off-label” in
patients with isolated CIA aneurysms. Five patients in our
series underwent IIA ﬂow preservation, three with a normal
aorta and two presenting with concomitant small aneurysms
in the distal aorta. Preservation of ﬂow to the IIA can be
achieved by several different methods. The Cook Iliac Branch
Device (IBD) is the only commercially available endograft (CE-
marked only) designed for this purpose. However, the IBD
requires the concomitant delivery of a Zenith Flex aortic
endograft. Five patients with a normal aorta in our series
would have required an endograft with suprarenal ﬁxation to
deliver the IBD in an off-label application. Several other off-
label methods to preserve ﬂow to the IIA have been
described.15e17 Unfortunately, all of them require a main-
body device delivered in the abdominal aorta. In this se-
ries, the median distance between the lower renal artery and
the proximal ILE landing zone was 5.3 cm (range 3e6.4 cm),
preserving a long segment of the native infrarenal aorta and
preserving ﬂow to the inferior mesenteric artery in four out
of ﬁve patients with isolated BCIAA. The untreated native
infrarenal aorta did not show any sign of aneurysmal dilation
during the follow-up. Viabahn grafts and targeted IIAs were
patent in all patients without any sign of stenosis or pelvic
ischemia at the end of a median follow-up (for this subgroup)
of 25 months (range 14e40 months).
CONCLUSION
The results of the present study show that PG-EVAR is a
straightforward technique in the treatment of patients pre-
senting asymmetric AAA or bilateral iliac aneurysms with a
long aortic neck. PG-EVAR may represent a suitable “off-la-
bel” approach in some of these rare aneurysm presentations
when standard EVAR is contraindicated. Preservation of ﬂow
to one IIA was easily accomplished without any targeted IIA
occlusion and/or any evidence of pelvic ischemia. Although
the number of treated patients is low, the median 26-month
follow-up results of this technique are very encouraging
without any evidence of type I and III endoleaks.
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